Cell differentiation and the multiple drug resistance phenotype in human erythroleukemic cells

Leuk Res. 2016 Mar:42:13-20. doi: 10.1016/j.leukres.2016.01.008. Epub 2016 Jan 21.

Abstract

The gene expression of Oct-4, a transcription factor and hematopoietic stem cell marker, is higher in Lucena lines, which is MDR, and the gene Alox-5 has also been implicated in the differentiation of some cell lines. The aim of this study was to compare the response to PMA-induced differentiation in MDR and non-MDR cells. We observed the differentiation to megakaryocytes in the K562 cell line, which is non-MDR. The expression of Alox-5 and Nanog genes was downregulated and that of Mdr-1 was upregulated in K562 cells. The Lucena cell line contained a higher number of megakaryocytes than the non-MDR, but this number was not altered by PMA, as well as Mdr-1 gene expression. However, Alox-5 expression was downregulated. Alox-5, Mdr-1, Nanog, Oct-4 and Sox-2 basal expression was also evaluated in the K562, Lucena and FEPS (also MDR) cell lines. The transcription factors gene expression was similar in MDR cell lines. The expression of Alox-5 was higher in the non-MDR cell line, while FEPS had the lowest expression of this gene. The opposite pattern was observed for Mdr-1 gene expression. These results suggest that the Alox-5 gene might play a role in the differentiation of these cell lines.

Keywords: Alox-5; Differentiation; Leukemia; MDR; PMA; Tumoral stem cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arachidonate 5-Lipoxygenase / genetics*
  • Cell Differentiation / genetics*
  • Drug Resistance, Multiple / genetics*
  • Humans
  • K562 Cells
  • Leukemia, Erythroblastic, Acute / genetics*
  • Leukemia, Erythroblastic, Acute / pathology
  • Neoplastic Stem Cells / pathology*
  • Phenotype
  • Polymerase Chain Reaction
  • Transcriptome

Substances

  • Arachidonate 5-Lipoxygenase
  • ALOX5 protein, human